Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5272931
Chembl Id: CHEMBL5272931
Max Phase: Preclinical
Molecular Formula: C34H48N6O5S
Molecular Weight: 652.86
Associated Items:
ID: ALA5272931
Chembl Id: CHEMBL5272931
Max Phase: Preclinical
Molecular Formula: C34H48N6O5S
Molecular Weight: 652.86
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CN3CCCCC3)nc3[nH]cnc23)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C34H48N6O5S/c1-6-32(4)16-23(33(5)20(2)10-12-34(21(3)28(32)44)13-11-22(41)27(33)34)45-25(43)18-46-30-26-29(36-19-35-26)38-31(39-30)37-24(42)17-40-14-8-7-9-15-40/h6,19-21,23,27-28,44H,1,7-18H2,2-5H3,(H2,35,36,37,38,39,42)/t20-,21+,23-,27?,28+,32-,33+,34+/m1/s1
Standard InChI Key: IYWSDQDVEPTFNW-SIZKMEIFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 652.86 | Molecular Weight (Monoisotopic): 652.3407 | AlogP: 4.78 | #Rotatable Bonds: 8 |
Polar Surface Area: 150.40 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.65 | CX Basic pKa: 6.72 | CX LogP: 4.39 | CX LogD: 4.12 |
Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.16 | Np Likeness Score: 0.51 |
1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y.. (2023) Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives., 14 (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004] |
Source(1):